Single domain antibody and derivative proteins thereof against CTLA4
US11091549B2 · kind B2 · utility
2Cited by
0References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 19, 2017 |
| Grant date | Aug 17, 2021 |
| Priority date | — |
| Expiry date | Aug 1, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the field of medical biology, and discloses a single domain antibody and derivative proteins thereof against CTLA4. In particular, the present invention discloses a CTLA4 binding protein and the use thereof, especially the use for treating and/or preventing CTLA4 relevant diseases such as tumor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.